CFC-powered inhalers inclusion in FDA reform bill agreed to by Sen. Kennedy.
This article was originally published in The Gray Sheet
Executive SummarySEN. KENNEDY TO SUPPORT INCLUSION OF CFC-POWERED INHALERS BILLS IN S 830 during conference of the FDA reform bill. The Massachusetts Democrat is understood to be willing to accept the inclusion of Sen. Tim Hutchinson's (R-Ark.) S 1299, and its companion legislation in the House, Rep. Mark Foley's (R-Fla.) HR 2627, which would prevent FDA from banning metered-dose inhalers for asthma which use chlorofluorocarbons as the propellant until acceptable alternative products are available.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.